Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerability.
about
Partial loss of genes might open therapeutic window.Molecular basis of differential 3' splice site sensitivity to anti-tumor drugs targeting U2 snRNP.Therapeutic Applications of Targeted Alternative Splicing to Cancer Treatment.Insights from structures of cancer-relevant pre-mRNA splicing factors.Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.
P2860
Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerability.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Copy-number and gene dependenc ...... a novel cancer vulnerability.
@en
type
label
Copy-number and gene dependenc ...... a novel cancer vulnerability.
@en
prefLabel
Copy-number and gene dependenc ...... a novel cancer vulnerability.
@en
P2093
P2860
P50
P356
P1433
P1476
Copy-number and gene dependenc ...... s a novel cancer vulnerability
@en
P2093
Barbara A Weir
Belinda Wang
Benjamin L Ebert
Caitlin A Nichols
Charles D Stiles
David E Root
Dirk Heckl
Esther A Obeng
Glenn S Cowley
P2860
P356
10.7554/ELIFE.23268
P407
P577
2017-02-08T00:00:00Z